Rahul Seth Selected Research

Rahul Seth Research Topics

Disease

11	Neoplasms (Cancer) 12/2021 - 06/2004
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 03/2007
3	Squamous Cell Carcinoma of Head and Neck 11/2019 - 04/2010
2	Seroma 07/2022 - 04/2022
2	Hematoma 07/2022 - 04/2022
2	Melanoma (Melanoma, Malignant) 01/2022 - 11/2020
2	Wounds and Injuries (Trauma) 01/2016 - 11/2010
1	Gender Dysphoria 07/2021
1	Thrombosis (Thrombus) 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021
1	COVID-19 01/2021
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 12/2020
1	Uveal melanoma 11/2020
1	Multiple Myeloma 10/2019
1	Leiomyosarcoma 01/2019
1	Liposarcoma 01/2019
1	Infections 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Acidosis 01/2018
1	Lung Neoplasms (Lung Cancer) 09/2017
1	Gustatory Sweating (Frey's Syndrome) 08/2016
1	Necrosis 11/2015
1	Congenital Abnormalities (Deformity) 05/2014
1	Horner Syndrome (Horner's Syndrome) 03/2014
1	Facial Nerve Injuries 11/2012
1	Pathologic Constriction (Stenosis) 11/2012
1	Inflammation (Inflammations) 04/2012
1	Tonsillar Neoplasms 01/2012
1	Carcinoma (Carcinomatosis) 01/2012
1	Neoplasm Metastasis (Metastasis) 11/2011
1	Cerebrospinal Fluid Leak 11/2010
1	Fistula 11/2010
1	Spontaneous Fractures (Pathological Fracture) 11/2010
1	Osteonecrosis (Kienbock's Disease) 11/2010
1	Intractable Pain 11/2010
1	Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) 11/2010
1	Rhinosinusitis 05/2010
1	Osteoporosis 05/2010
1	Metabolic Bone Diseases (Osteopenia) 05/2010
1	Hearing Loss (Hearing Impairment) 10/2007
1	Long QT Syndrome 05/2007
1	Disease Progression 05/2007
1	Nausea 06/2004
1	Lymphoma (Lymphomas) 06/2004
1	Vomiting 06/2004

Drug/Important Bio-Agent (IBA)

2	NivolumabIBA 12/2020 - 11/2020
2	Fluorescein (Funduscein)FDA LinkGeneric 11/2015 - 11/2010
2	GlucocorticoidsIBA 11/2012 - 05/2010
1	Polysaccharides (Glycans)IBA 07/2022
1	SolutionsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 12/2020
1	dabrafenibIBA 11/2020
1	encorafenibIBA 11/2020
1	VemurafenibIBA 11/2020
1	cobimetinibIBA 11/2020
1	IpilimumabIBA 11/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020
1	binimetinibIBA 11/2020
1	pembrolizumabIBA 11/2020
1	trametinibIBA 11/2020
1	TrabectedinIBA 01/2019
1	Dacarbazine (DIC)FDA LinkGeneric 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	KetonesIBA 01/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2015
1	antineoplaston A10 (A 10)IBA 05/2014
1	CatecholaminesIBA 03/2014
1	Transforming Growth Factor-beta Type II ReceptorIBA 04/2012
1	16S Ribosomal RNAIBA 04/2012
1	Interleukin-8 (Interleukin 8)IBA 04/2012
1	Acetazolamide (Diamox)FDA LinkGeneric 11/2010
1	Diphosphonates (Bisphosphonates)IBA 11/2010
1	SteroidsIBA 05/2010
1	GadoliniumIBA 10/2007
1	Potassium Channels (Potassium Channel)IBA 05/2007
1	Proteins (Proteins, Gene)FDA Link 05/2007
1	Ion Channels (Ion Channel)IBA 05/2007
1	dolasetron (Anzemet)FDA Link 06/2004
1	Serotonin (5 Hydroxytryptamine)IBA 06/2004
1	Granisetron (Kytril)FDA LinkGeneric 06/2004
1	AntiemeticsIBA 06/2004

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2007
7	Free Tissue Flaps 07/2022 - 11/2010
3	Radiotherapy 09/2017 - 04/2010
2	Operative Time 01/2021 - 05/2017
2	Mohs Surgery (Mohs' Micrographic Surgery) 11/2011 - 04/2011
1	Sex Reassignment Surgery 07/2021
1	Tendon Transfer 01/2021
1	Neoadjuvant Therapy 11/2020
1	Transplantation 10/2019
1	Adjuvant Chemotherapy 09/2017
1	Lasers (Laser) 11/2012
1	Immunomodulation 11/2012
1	Oral Hygiene (Dental Hygiene) 04/2012
1	Tonsillectomy 01/2012
1	Craniotomy 11/2011
1	Conservative Treatment 11/2010
1	Drug Therapy (Chemotherapy) 06/2004